News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Nanobiotix begins patient dosing in new randomized phase 2 …
1 day ago · Nanobiotix, a late-clinical stage biotechnology company pioneering nanoparticle-based therapeutic approaches to expand treatment possibilities for patients with cancer and …
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Editorial - Pharmabiz.com
Nov 6, 2024 · Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic …
Lilly's Omvoh receives US FDA approval to treat Crohn's disease in …
6 days ago · Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that …
Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval …
3 days ago · Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval for patients with previously treated metastatic HR positive, HER2 negative breast cancer
US FDA accepts and grants priority review status to Dizal’s ...
Jan 9, 2025 · Dizal, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the US Food and Drug …
Annovis Bio gets US FDA clearance to begin pivotal phase 3 …
Oct 17, 2024 · Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, …
Pfizer’s Hympavzi receives US FDA approval to treat adults and ...
Oct 14, 2024 · Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST]
US FDA clears Tyra Biosciences’ IND application to proceed with …
Oct 29, 2024 · US FDA clears Tyra Biosciences’ IND application to proceed with phase 2 study of TYRA-300 in paediatric achondroplasia: Carlsbad, California Tuesday, October 29, 2024, …